Trade Secrets Protection: Elevance vs. Hamaspik Poaching Allegations

The intricate landscape of managed care is currently roiled by a significant legal dispute, bringing the critical issue of trade secrets protection into sharp focus. Elevance Health has initiated a lawsuit against rival managed care organization Hamaspik, Inc., alleging a “coordinated scheme” to poach key staff and illicitly acquire confidential operational blueprints for its high-value Medicare-Medicaid plans. This case highlights the aggressive competition and legal challenges within the insurance sector, emphasizing the constant battle for trade secrets protection.

Allegations of a Coordinated Scheme

Elevance Health’s complaint, filed on July 27, 2026, in the US District Court for the Southern District of New York, targets Hamaspik, Inc., along with four of Elevance’s own former employees. This legal action details what Elevance describes as a calculated effort, ongoing since December 2025, to undermine its competitive standing. The core of the allegation centers on Hamaspik’s purported strategy to hire individuals responsible for managing Elevance’s New York Managed Long-Term Care (MLTC) and Fully Integrated Dual Eligible Special Needs (FIDE) plans.

These integrated plans, combining Medicare and Medicaid coverage into a single product, represent a complex and highly profitable segment of the managed care market. Elevance asserts that “no less than seven” former staff members have been recruited by Hamaspik, each now reportedly performing “substantially similar work” for the competitor. Is this simply competitive hiring, or something far more problematic? The complaint contends that Hamaspik’s ultimate goal is to “recreate, at a fraction of the cost,” the robust operational infrastructure Elevance meticulously built.

This infrastructure was significantly bolstered by Elevance’s acquisition of Centers Plan for Healthy Living and a related business, effective December 31, 2024, an investment described in the filing as “hundreds of millions of dollars.” Such allegations underscore the intense pressures within the healthcare insurance industry, where innovation and operational efficiency are paramount. The value of proprietary processes—developed over years and at significant expense—becomes a central battleground when key personnel depart. How can companies safeguard their intellectual capital in such a dynamic environment? The legal filings paint a picture of a deliberate strategy, not merely incidental departures. This situation raises fundamental questions about the ethical boundaries of competition and the legal ramifications for those who cross them. It also highlights the constant vigilance required from organizations to protect their competitive edge.

The Alleged Data Exfiltration

Beyond the staff poaching, the lawsuit presents grave concerns regarding the alleged exfiltration of sensitive, proprietary information. Elevance’s complaint highlights specific instances of data transfer to personal accounts by departing employees. Notably, a former director who oversaw FIDE operations is alleged to have sent at least nine emails to a personal email account on June 21 and 22, 2026. One of these emails alone contained 53 attachments, and this individual reportedly took “approximately 192 documents” before resigning.

Among the documents allegedly compromised are a proprietary health-risk-assessment workflow, a roughly 193-page “D-SNP Model of Care” — which the filing explicitly calls “the complete operational blueprint” for such a plan — and an internal “Stars Overview” document. This “Stars Overview” is particularly critical, as it is tied directly to the CMS star ratings, which significantly impact bonus payments and market competitiveness within the Medicare-Medicaid landscape. Further allegations include a former sales manager emailing a “more than 400-page” events tracker, along with compensation and forecast documents, to themselves. A former network director is also accused of emailing template provider agreements, training materials, and rate information. These actions, if proven, represent a severe breach of trust and a direct attack on Elevance’s investment in its intellectual property, specifically undermining its trade secrets protection.

Companies often require highly paid staff to agree to explicit post-employment restrictions, including non-compete clauses, in exchange for benefits such as stock rights. Here, two individual defendants, including the former FIDE operations director and a former claims director, allegedly agreed not to take a “Competitive Position” with a rival for the greater of their severance period or twelve months. They were also mandated to notify Elevance’s chief human resources officer within five business days of any competing offer. The complaint asserts that neither provided such notice. The ramifications for trade secrets protection are profound, extending beyond mere data loss to the erosion of competitive advantage.

“The alleged theft of a ‘complete operational blueprint’ for a Medicare-Medicaid plan goes beyond mere competitive intelligence gathering; it suggests an attempt to shortcut years of development and significant financial outlay.”

The Stakes of Competitive Advantage

The legal battle between Elevance Health and Hamaspik underscores the immense value placed on operational methodologies and strategic insights within the managed care industry. Elevance explicitly links the former FIDE operations director’s work to the plan achieving a coveted five-star CMS rating, a distinction directly translating to substantial bonus payments and a superior competitive standing. Once proprietary methods and strategic blueprints are compromised, can the original advantage truly be restored? Elevance argues that it cannot.

The complaint levies eight counts against the defendants, reflecting the multi-faceted nature of the alleged wrongdoing. These include breach of non-compete, non-solicitation, and confidentiality terms—fundamental pillars of employment agreements designed to protect corporate assets. Further serious allegations involve tortious interference, a violation of the federal Defend Trade Secrets Act, and misappropriation of trade secrets under New York law. Other charges encompass unfair competition and civil conspiracy. Elevance is seeking various remedies, including injunctions to halt the alleged illicit activities, the return and permanent deletion of its confidential information, significant damages, and a jury trial to resolve the matter.

This case serves as a crucial reference point for other carriers navigating the intricate balance of protecting their talent and proprietary processes while facing aggressive recruitment tactics from competitors. The financial services and insurance sectors, in particular, are grappling with an environment where data, algorithms, and unique service delivery models are increasingly the core differentiators. The allegations, though yet to be tested in court, illustrate the critical need for robust internal controls and legal frameworks to secure intellectual property and maintain effective trade secrets protection. Without adequate protection, the incentive for innovation diminishes, potentially stifling advancements across the industry. This case sets a precedent for how extensively companies must go to ensure their trade secrets protection mechanisms are unassailable.

What Should Insurers Do About Trade Secrets Protection?

The Elevance Health lawsuit provides a stark reminder of the vulnerabilities companies face concerning trade secrets protection and employee mobility. For insurers and managed care organizations, proactive measures are not just advisable but essential. What steps can be taken to fortify defenses against such alleged schemes and bolster overall trade secrets protection?

Firstly, strengthening employment contracts is paramount. These agreements must clearly define what constitutes confidential information and trade secrets, and stipulate robust non-compete, non-solicitation, and confidentiality clauses that are enforceable under relevant state and federal laws, thereby reinforcing trade secrets protection. Regular reviews of these contracts, especially for key personnel, can ensure they remain relevant and legally sound. Secondly, implementing stringent data access and monitoring protocols is critical. Companies should track who accesses sensitive documents, when, and from where. Advanced data loss prevention (DLP) solutions can prevent employees from emailing or transferring confidential files to unauthorized personal accounts or external drives. This isn’t about distrust; it’s about safeguarding invaluable corporate assets and ensuring diligent trade secrets protection.

Furthermore, a comprehensive off-boarding process for departing employees is crucial. This should include reminding them of their ongoing contractual obligations, conducting exit interviews to understand their future roles, and immediately revoking all system access. Forensic analysis of company-issued devices can also uncover potential data exfiltration before it leads to irreparable harm. Finally, cultivating a strong ethical culture where employees understand the value and importance of proprietary information can serve as an additional deterrent. The current legal dispute underscores that the cost of inaction far outweighs the investment in robust strategies for trade secrets protection. Companies must continuously evolve their strategies to protect their intellectual property in an increasingly competitive and data-driven marketplace, recognizing that trade secrets protection is an ongoing battle.

Managed Care Legal Allegations – Disclaimer

The insights provided regarding the Elevance Health and Hamaspik legal dispute are for informational and research purposes only and should not be construed as legal advice. This article does not offer specific guidance on litigation strategy, intellectual property law, or employment contract drafting. Outcomes in legal cases vary widely based on specific facts and jurisdiction. Readers facing similar challenges should consult with qualified legal professionals for advice tailored to their individual circumstances.